Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Thousands More Medtech Jobs At Risk If Tax Restarts, Think Tank Says

Executive Summary

The center-right American Action Forum says whether the US Congress elects to permanently repeal the device excise take or let tax collection restart in 2018 will have stark implications for medtech jobs.

You may also be interested in...



Health Reform Roundtable Members Hold Conflicting Views On Device Tax Repeal For ACA Reform

A group of high-level health policy analysts – including former Medicare and Medicaid officials and experts at policy groups including Families USA and the American Enterprise Institute – have crafted a bipartisan recommendation for Affordable Care Act reform, but are divided on if the 2.3% device excise tax created by ACA should be repealed.

Device-Tax Repeal Opportunity Slips Away As GOP Pulls Health Bill From Consideration

The House Republican conference decision to pull the American Health Care Act from consideration means repeal of the medical device tax has died, at least in the short term. After hours of debate on the floor, and failing to gather enough votes to pass the bill, House Speaker Paul Ryan and President Trump called a halt to the Affordable Care Act repeal effort, saying they will now focus on other objectives, such as tax reform.

Device-Tax Repeal In Doubt As House Postpones Health Bill Vote

US House Republicans canceled a planned vote on the "repeal and replace" American Health Care Act March 23 after failing to secure enough support to ensure passage of the measure. Republicans are still trying salvage a compromise, but the developments threaten industry's goal of achieving a permanent repeal of the medical device tax in the near term.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT104532

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel